Elsevier

World Neurosurgery

Volume 110, February 2018, Pages 20-25
World Neurosurgery

Literature Review
Systematic Review of Woven EndoBridge for Wide-Necked Bifurcation Aneurysms: Complications, Adequate Occlusion Rate, Morbidity, and Mortality

https://doi.org/10.1016/j.wneu.2017.10.113Get rights and content

Background

Although the Woven EndoBridge (WEB [Sequent Medical, Aliso Viejo, California, USA]) is a highly innovative technique for the endovascular treatment of wide-necked bifurcation aneurysms (WNBAs), there are no studies available comparing this technique with surgical results or other endovascular results of stent-assisted coiling or balloon-assisted coiling for WNBAs. The purpose of this study was to assess complications, complete occlusion rate, and morbidity and mortality of the WEB in WNBA treatment.

Methods

Published literature citing embolization results for WNBAs using the WEB was reviewed. A systematic review was performed to evaluate the complications, complete occlusion rate, and morbidity and mortality.

Results

We identified 19 studies, including 935 patients. The most frequent aneurysm locations were the bifurcation of the middle cerebral artery (MCA) (42.8%), the anterior communicating artery (23%), and the basilar bifurcation (20.8%). The technical success rate of the WEB was 97% (95% confidence interval [CI], 96%–98%). The thromboembolic complication rate was 8% (95% CI, 6%–11%). The thromboembolic complication rate was 10% (95% CI, 7%–13%) in cases before 2013, which was higher than in cases after 2013 (6%; 95% CI, 4%–9%; P = 0.045). MCA bifurcation aneurysm has a higher thromboembolic complication rate than posterior circulation aneurysm. The overall bleeding complication rate of the WEB was 2% (95% CI, 1%–3%). The adequate occlusion rate was 81% (95% CI, 76%–85%). Morbidity during follow-up was 3% (95% CI, 1%–4%) (I2 = 30.4%), and mortality was 2% (95% CI, 1%–3%).

Conclusions

Adequate aneurysm occlusion was found in 81% of WEB cases with low morbidity and mortality.

Introduction

Wide-necked bifurcation aneurysms (WNBA) are difficult to be treated endovascularly because bifurcation branches often arise from the aneurysm neck.1 This subgroup of aneurysms includes aneurysms located at internal carotid artery bifurcation, middle cerebral artery bifurcation, anterior communicating artery, and basilar artery bifurcation.1 Different strategies are available to treat both ruptured and unruptured aneurysms (stent-assisted coiling, Y-stenting, waffle-cone technique, and flow diversion), whereas some techniques are essentially restricted to unruptured aneurysms because of the need of concomitant use of antiplatelet medications.1 However, these techniques have yet to be evaluated in large prospective series. An intrasaccular flow disruption device (Woven EndoBridge [WEB] [Sequent Medical, Aliso Viejo, California, USA]) seems to be a promising tool for the endovascular treatment of WNBAs.2, 3, 4, 5 The WEB device has been evaluated with prospective multicenter studies showing high safety and good efficacy. However, the potential safety issues of this technique have to be assessed. It would be interesting to assess the effectiveness of WEB embolization and how it impacts the conventional endovascular techniques for WNBAs. Although 3 systematic reviews have been performed, these questions have not been answered clearly. There are no studies available comparing this technique with surgical results or other endovascular results of stent-assisted coiling or balloon-assisted coiling for WNBAs. In this review, we evaluated complications, complete occlusion rate, and morbidity and mortality of the WEB in WNBA treatment.

Section snippets

Methods

A systematic review search was done for available published studies on PubMed and Web of Science through June 2017. The keyword included in the search was “Woven EndoBridge device.” Studies were selected based on the following criteria: clinical studies, use of a WEB device, outcomes and complications related to the embolization procedures are reported. Exclusion criteria included case reports, studies not reporting on outcomes, and duplicated studies from a single center conducted in the same

Results

A total of 51 studies and abstracts were found in the primary search. After exclusion of duplicate, nonhuman, and irrelevant studies by abstract review, 22 studies were selected for full review; 19 studies met the selection criteria (Figure 1). A total of 19 studies were included in the analysis (Table 1). Six studies were prospective and 13 were retrospective, with a total of 935 patients with 967 aneurysms.6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 The most

Discussion

Our meta-analysis of 19 studies including 935 patients with 967 aneurysms treated with the WEB device demonstrated that the WEB device has a safety profile. The WEB is mostly dedicated to the treatment of WNBA. In a systematic review of 15 studies by Asnafi et al.,3 the authors reported complete and adequate occlusion rates were 39% and 85% at midterm follow-up. Perioperative morbidity rate was 4% and the mortality rate was 1%. Another 6 studies in a systematic review gave a similar result.2

Conclusions

Although adequate aneurysm occlusion was found in 81% of WEB cases, long-term results remain unknown, and no comparison has been made with currently available treatment options such as stent-assisted coiling. The WEB device has a potential role in the treatment of basilar bifurcation aneurysms, WNBAs with necks >7 mm, and/or those with a bifurcation angle >180°.

References (27)

  • L. Pierot et al.

    Endovascular techniques for the management of wide-neck intracranial bifurcation aneurysms: a critical review of the literature

    J Neuroradiol

    (2016)
  • X. Armoiry et al.

    Endovascular treatment of intracranial aneurysms with the WEB device: a systematic review of clinical outcomes

    AJNR Am J Neuroradiol

    (2016)
  • S. Asnafi et al.

    Efficacy and safety of the Woven EndoBridge (WEB) device for the treatment of intracranial aneurysms: a systematic review and meta-analysis

    AJNR Am J Neuroradiol

    (2016)
  • B. Mine et al.

    Intrasaccular flow-diversion for treatment of intracranial aneurysms: the Woven EndoBridge

    Expert Rev Med Devices

    (2014)
  • Muskens IS, Senders JT, Dasenbrock HH, Smith TR, Broekman ML. The Woven Endobridge device for treatment of intracranial...
  • L. Pierot et al.

    Intrasaccular flow-disruption treatment of intracranial aneurysms: preliminary results of a multicenter clinical study

    AJNR Am J Neuroradiol

    (2012)
  • B. Lubicz et al.

    WEB-DL endovascular treatment of wide-neck bifurcation aneurysms: short- and midterm results in a European study

    AJNR Am J Neuroradiol

    (2014)
  • L. Pierot et al.

    Endovascular WEB flow disruption in middle cerebral artery aneurysms: preliminary feasibility, clinical, and anatomical results in a multicenter study

    Neurosurgery

    (2013)
  • B. Mine et al.

    Follow-up of intracranial aneurysms treated by a WEB flow disrupter: a comparative study of DSA and contrast-enhanced MR angiography

    J Neurointerv Surg

    (2016)
  • C. Clajus et al.

    Initial and mid-term results from 108 consecutive patients with cerebral aneurysms treated with the WEB device

    J Neurointerv Surg

    (2017)
  • B. Lubicz et al.

    WEB device for endovascular treatment of wide-neck bifurcation aneurysms

    AJNR Am J Neuroradiol

    (2013)
  • T. Liebig et al.

    Intrasaccular flow disruption in acutely ruptured aneurysms: a multicenter retrospective review of the use of the WEB

    AJNR Am J Neuroradiol

    (2015)
  • C. Papagiannaki et al.

    WEB intrasaccular flow disruptor-prospective, multicenter experience in 83 patients with 85 aneurysms

    AJNR Am J Neuroradiol

    (2014)
  • Cited by (55)

    • Clinical audit comparing radiation dose metrics between WEB and coil embolisation in the treatment of intracranial aneurysms

      2022, Journal of Medical Imaging and Radiation Sciences
      Citation Excerpt :

      This functions as an intra-saccular flow disruption device, preventing blood from entering the aneurysm and allowing the aneurysm to clot off. Many studies have demonstrated the safety and efficiency of the WEB, with a recent systematic review showing aneurysm occlusion was found in 81% of cases and mortality rates as low as 3%.10 The WEB device has been shown to be a shorter procedure (109±69 min).7

    View all citing articles on Scopus

    Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    View full text